Loading
CT
Canntab Therapeutics Limited Stock: price and insider trades · Canada
Canntab Therapeutics Limited: what insiders have been doing
This page follows insider dealings at Canntab Therapeutics Limited as filed with SEDI. No insider at Canntab Therapeutics Limited has published a filing in the past twelve months. The most recent one dates from 22 February 2022.
Our records for Canntab Therapeutics Limited go back to 2018, with 18 purchases and 1 sale on the open market in total.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
35
Thresholds
n/a
Buy Volume
€393,188
18 ops. · all time
Sell Volume
n/a
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 22 February 2022
Declarations35 total
400,000 sharesCommon SharesTSXSEDI:3889105
200,000 shares@ CA$0.7217.7% of flowCommon SharesTSXSEDI:3883868
Canonical exit: 11 May 2022 (T+90)
110,000 shares@ CA$0.74510.0% of flowCommon SharesTSXSEDI:3883864
Canonical exit: 8 May 2022 (T+90)
94,000 shares@ CA$0.2538.4% of flowCommon SharesTSXSEDI:3882451
200,000 sharesCommon SharesTSXSEDI:3871670
40,000 shares@ CA$0.7129.8% of flowCommon SharesTSXSEDI:3810923
Canonical exit: 28 Dec 2021 (T+90)
95,000 shares@ CA$0.69870.2% of flowCommon SharesTSXSEDI:3810941
Canonical exit: 30 Dec 2021 (T+90)
300,000 shares@ CA$0.7538.1% of flowCommon SharesTSXSEDI:3759407
20,000 shares@ CA$0.963.3% of flowCommon SharesTSXSEDI:3759398
Canonical exit: 2 Sept 2021 (T+90)
20,000 shares@ CA$0.752.5% of flowCommon SharesTSXSEDI:3759402
20,000 shares@ CA$0.75100.0% of flowCommon SharesTSXSEDI:3759181
40,000 shares@ CA$1.006.8% of flowCommon SharesTSXSEDI:3738859
Canonical exit: 3 Aug 2021 (T+90)
20,000 shares@ CA$1.103.7% of flowCommon SharesTSXSEDI:3738861
Canonical exit: 3 Aug 2021 (T+90)
100,000 shares@ CA$1.0016.6% of flowCommon SharesTSXSEDI:3733714
Canonical exit: 22 Jul 2021 (T+90)
2,800 shares@ CA$1.0660.5% of flowCommon SharesTSXSEDI:3708704
Canonical exit: 15 Jun 2021 (T+90)
25,000 shares@ CA$1.054.4% of flowCommon SharesTSXSEDI:3708705
Canonical exit: 15 Jun 2021 (T+90)
6,600 shares@ CA$1.051.2% of flowCommon SharesTSXSEDI:3708703
Canonical exit: 15 Jun 2021 (T+90)
21,000 shares@ CA$1.023.6% of flowCommon SharesTSXSEDI:3704221
Canonical exit: 10 Jun 2021 (T+90)
4,000 shares@ CA$1.0030.7% of flowCommon SharesTSXSEDI:3704220
Canonical exit: 10 Jun 2021 (T+90)
Common SharesTSXSEDI:3704217
100,000 shares@ CA$0.2561.2% of flowCommon SharesTSXSEDI:3670755
95,000 sharesCommon SharesTSXSEDI:3666728
Canonical exit: 21 Apr 2021 (T+90)
111,000 sharesCommon SharesTSXSEDI:3666101
Canonical exit: 20 Apr 2021 (T+90)
Common SharesTSXSEDI:3594726
20,000 shares@ CA$0.501.2% of flowCommon SharesTSXSEDI:3507041
25 of 35 declarations
About Canntab Therapeutics Limited
Canntab Therapeutics Limited is a company focused on developing pharmaceutical products based on cannabis. It is listed on the Toronto Stock Exchange (XTSE).
